glp-1 colorectal cancer risk study november 2025 death use linked to better survival rates in Mapping the effectiveness and risks – Association between GLP-1 receptor agonists

doi:10.1080/13697137.2020.1828854

We know, for example, that [15] small intestinal bacterial overgrowth (SIBO) is commonly found with Hashimotos (a 2007 study found that about 50 percent of people with hypothyroidism have this infection), and is associated with slow gut motility and intestinal permeability

Clinical studies have shown that AOD 9604 can reduce body fat, especially in the abdominal area, without the side effects linked to growth hormone therapy

Although rodent studies consistently show thyroid C-cell tumors, human relevance remains uncertain due to marked species differences in GLP-1 receptor expression